Your browser doesn't support javascript.
loading
CRISPR/Cas9: a powerful tool in colorectal cancer research.
Hu, Yang; Liu, Liang; Jiang, Qi; Fang, Weiping; Chen, Yazhu; Hong, Yuntian; Zhai, Xiang.
Affiliation
  • Hu Y; Department of Gastroenterology, The First People's Hospital of Jiande, Hangzhou, 311600, China.
  • Liu L; Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Jiang Q; Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Fang W; Department of Gastroenterology, The First People's Hospital of Jiande, Hangzhou, 311600, China.
  • Chen Y; West China Hospital of Sichuan University, Chengdu, 610044, China. yazhu.chen@qq.com.
  • Hong Y; Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. 3130101818@zju.edu.cn.
  • Zhai X; Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. zx1996@whu.edu.cn.
J Exp Clin Cancer Res ; 42(1): 308, 2023 Nov 22.
Article in En | MEDLINE | ID: mdl-37993945

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / CRISPR-Cas Systems Limits: Animals / Humans Language: En Journal: J Exp Clin Cancer Res Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / CRISPR-Cas Systems Limits: Animals / Humans Language: En Journal: J Exp Clin Cancer Res Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido